Deep insight into the correlation between gut dysbiosis and alzheimer’s amyloidopathy (Record no. 19458)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | a |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20230526105008.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 230526b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | AIKTC-KRRC |
| Transcribing agency | AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 20979 |
| Author | Kondaveeti, Sreenivasulu Naidu |
| 245 ## - TITLE STATEMENT | |
| Title | Deep insight into the correlation between gut dysbiosis and alzheimer’s amyloidopathy |
| 250 ## - EDITION STATEMENT | |
| Volume, Issue number | Vol.13(4), Dec |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | New Delhi |
| Name of publisher, distributor, etc. | SAGE |
| Year | 2022 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Pagination | 305-315p. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Recent research has shown a strong correlation between gut dysbiosis and Alzheimer’s disease (AD). The purpose of this review is to investigate the relationship between gut dysbiosis, immune system activation, and the onset of AD and to examine current breakthroughs in microbiota-targeted AD therapeutics. A review of scientific literature was conducted to assess the correlation between gut dysbiosis and AD and the various factors associated. Gut dysbiosis produces an increase in harmful substances, such as bacterial amyloids, which makes the gut barrier and blood-brain barrier more permeable. This leads to the stimulation of immunological responses and an increase in cytokines such as interleukin-1β (IL-1β). As a result, gut dysbiosis accelerates the progression of AD. The review highlights the connection between gut dysbiosis and AD and the potential for microbiota-targeted therapies in AD treatment. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 4774 |
| Topical term or geographic name entry element | PHARMACOLOGY |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 19752 |
| Co-Author | Thekkekkara, Dithu |
| 773 0# - HOST ITEM ENTRY | |
| International Standard Serial Number | 0976-500X |
| Title | Journal of pharmacology and pharmacotherapeutics |
| Place, publisher, and date of publication | New Delhi SAGE Publications |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| URL | https://journals.sagepub.com/doi/epub/10.1177/0976500X221150310 |
| Link text | Click here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Articles Abstract Database |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent Location | Current Location | Shelving location | Date acquired | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| School of Pharmacy | School of Pharmacy | Archieval Section | 2023-05-26 | 2023-0875 | 2023-05-26 | 2023-05-26 | Articles Abstract Database |